ORLANDO,
Fla., July 23, 2024 /PRNewswire/ -- Alcanza
Clinical Research, a mission-focused investigator site network, is
excited to announce its affiliation with The Society of Clinical
Research Sites (SCRS) as a Global Impact Partner. The GIP program
is a community of industry sponsors, CROs, service providers and
research sites elevating the site voice within clinical
research.
Since its inception in 2021, Alcanza has been an active
supporter of SCRS initiatives. As a past president, and current
board member of SCRS, Alcanza's Chief Commercial Officer,
Casey Orvin, remains highly engaged
and committed to expanding awareness and industry involvement with
SCRS. As a Global Impact Partner, Alcanza will help drive SCRS'
mission of ensuring site sustainability through advocacy, thought
leadership, event participation and education.
"Strengthening our commitment to SCRS is a core part of
our growth strategy," said Carlos
Orantes, Alcanza CEO. "SCRS understands the power of
collaboration, especially when it involves advancing life-changing
and life-saving new medicines. The GIP program is an excellent
example of effective collaboration across large site networks,
emerging sites, sponsors, CROs and solution providers – the
stakeholders who make positive change and progress possible."
Sean Soth, Senior Vice President
of Business Partnerships and Strategy with SCRS added, "Alcanza is
a forward-looking organization that epitomizes the expanding role
of the research site. By extending traditional research boundaries
through their emphasis on diverse participation and community
partners, Alcanza is setting a new standard for inclusive research
that will benefit all site members and the broader clinical
research community. SCRS looks forward to collaborating with
Alcanza to advance our collective mission to enhance site
sustainability."
For more information about SCRS Global Impact Partners, visit
https://myscrs.org.
About Alcanza Clinical Research
Alcanza is an integrated network of research facilities
dedicated to reducing barriers to clinical research participation,
especially in underrepresented patient populations. The network
includes 24 dedicated sites with several embedded sites
strategically located across the Southeast, Northeast, and Midwest
regions of the United States,
including Puerto Rico. Alcanza supports studies that span all
trial phases and major therapeutic areas.
https://www.alcanzaclinical.com/
Contact: pr@alcanzaclinical.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alcanza-clinical-research-joins-scrs-global-impact-partner-program-302203925.html
SOURCE Alcanza Clinical Research